Benchmark Maintains Speculative Buy on HeartBeam, Lowers Price Target to $5

Benzinga Newsdesk www.benzinga.com Negative 70.5%

Neg 70.5% Neu 0% Pos 0%

Benchmark analyst Bill Sutherland maintains HeartBeam (NASDAQ:BEAT) with a Speculative Buy and lowers the price target from $8 to $5.